Trial · NCT01244763
Adverse events306
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 306
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Urinary Tract Infection | Infections and infestations | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | 0 | 24 | |
| other | Urinary Tract Infection | Infections and infestations | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | 4 | 24 | |
| other | Urinary Tract Infection | Infections and infestations | Cohort C: Roxadustat at 50 mg TIW | 2 | 24 | |
| other | Urinary Tract Infection | Infections and infestations | Cohort D: Roxadustat at 100 mg TIW | 1 | 24 | |
| other | Urinary Tract Infection | Infections and infestations | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | 4 | 24 | |
| other | Urinary Tract Infection | Infections and infestations | Cohort F: Roxadustat at 70 mg BIW Then QW | 3 | 25 | |
| other | Nasopharyngitis | Infections and infestations | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | 2 | 24 | |
| other | Nasopharyngitis | Infections and infestations | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | 2 | 24 | |
| other | Nasopharyngitis | Infections and infestations | Cohort C: Roxadustat at 50 mg TIW | 2 | 24 | |
| other | Nasopharyngitis | Infections and infestations | Cohort D: Roxadustat at 100 mg TIW | 2 | 24 | |
| other | Nasopharyngitis | Infections and infestations | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | 3 | 24 | |
| other | Nasopharyngitis | Infections and infestations | Cohort F: Roxadustat at 70 mg BIW Then QW | 2 | 25 | |
| other | Sinusitis | Infections and infestations | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | 2 | 24 | |
| other | Sinusitis | Infections and infestations | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | 3 | 24 | |
| other | Sinusitis | Infections and infestations | Cohort C: Roxadustat at 50 mg TIW | 2 | 24 | |
| other | Sinusitis | Infections and infestations | Cohort D: Roxadustat at 100 mg TIW | 1 | 24 | |
| other | Sinusitis | Infections and infestations | Cohort E: Roxadustat Tiered, Weight Based Dosing BIW Then QW | 0 | 24 | |
| other | Sinusitis | Infections and infestations | Cohort F: Roxadustat at 70 mg BIW Then QW | 0 | 25 | |
| other | Nausea | Gastrointestinal disorders | Cohort A: Roxadustat Tiered, Weight Based Dosing TIW | 4 | 24 | |
| other | Nausea | Gastrointestinal disorders | Cohort B: Roxadustat Tiered, Weight Based Dosing TIW Then BIW | 1 | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01244763/events